You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Malignant Glioma

Showing 1 - 25 of 4,916
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

Completed
  • Malignant Glioma
  • +3 more
  • Dendritic Cell Vaccine
  • +3 more
  • Miami, Florida
    University of Miami
Jul 19, 2022

Recurrent Malignant Glioma Trial in Goyang-si (YYB-103)

Recruiting
  • Recurrent Malignant Glioma
  • Goyang-si, Gyeonggi, Korea, Republic of
    National Cancer Center, Korea
Sep 12, 2022

Malignant Glioma, Brain Tumor, Recurrent Trial in Durham (D2C7-IT)

Active, not recruiting
  • Malignant Glioma
  • Brain Tumor, Recurrent
  • Durham, North Carolina
    Preston Robert Tisch Brain Tumor Center at Duke
Jul 12, 2022

Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

Completed
Has Results
  • Glioma
  • +7 more
  • Neural stem cells loaded with an oncolytic adenovirus
  • Duarte, California
  • +1 more
Dec 28, 2022

Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)

Not yet recruiting
  • Malignant Glioma
  • Glioblastoma
  • hEGFRvIII-CD3 (BRiTE)
  • Activated Cell Therapy
  • Durham, North Carolina
    Duke University Medical Center
Jun 24, 2022

Chemo-radiation Induced Nausea and Vomiting Trial in Durham (Rolapitant, Ondansetron)

Completed
  • Chemo-radiation Induced Nausea and Vomiting
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Dec 12, 2022

Malignant Glioma Trial in United States (PVSRIPO)

Active, not recruiting
  • Malignant Glioma
  • PVSRIPO
  • San Francisco, California
  • +5 more
Jun 28, 2022

GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))

Completed
Has Results
  • GBM
  • +3 more
  • Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
  • Durham, North Carolina
    Duke University Medical Center
Jun 28, 2022

High-grade Glioma, Solid Tumor, Unspecified, Child Trial in Edison (2-OHOA)

Recruiting
  • High-grade Glioma
  • Solid Tumor, Unspecified, Child
  • Edison, New Jersey
    Hackensack Meridian Health, Inc
Aug 16, 2022

Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)

Terminated
  • Brain and Central Nervous System Tumors
  • Chicago, Illinois
    Rush Cancer Institute at Rush University Medical Center
Jan 5, 2023

Glioma, Malignant Trial in Durham (D2C7-IT, 2141-V11)

Recruiting
  • Glioma, Malignant
  • Durham, North Carolina
    Duke University Medical Center
Jul 27, 2022

Malignant Glioma Trial in Rochester (Fluorine-18-L-dihydroxyphenylalanine)

Active, not recruiting
  • Malignant Glioma
  • Rochester, Minnesota
    Mayo Clinic
Oct 10, 2022

Glioblastoma, IDH-wildtype Trial in France, Italy (Metformin, Radiation IMRT, Temozolomide)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • Suresnes, Hauts De Seine, France
  • +5 more
Aug 2, 2022

Recurrent Medulloblastoma, Recurrent Brain Tumor, Childhood, Malignant Glioma Trial in Durham (PEP-CMV)

Recruiting
  • Recurrent Medulloblastoma
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jan 8, 2022

Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)

Recruiting
  • Malignant Glioma
  • Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Oct 13, 2022

Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)

Recruiting
  • Glioma
  • +4 more
  • 3T MRI scanner
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Gliomas Using a Broad Next Generation Sequencing (NGS)Panel

Completed
  • Malignant Glioma
    • (no location specified)
    Aug 2, 2022

    Recurrent Glioblastoma Multiforme (GBM), Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma, Grade 3 or 4 Astrocytoma

    Recruiting
    • Recurrent Glioblastoma Multiforme (GBM)
    • +3 more
    • Los Angeles, California
    • +4 more
    May 5, 2022

    Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)

    Active, not recruiting
    • Glioblastoma
    • Recurrent Glioblastoma
    • Boston, Massachusetts
    • +3 more
    Jan 13, 2023

    Malignant Glioma, Anxiety, Caregiver Burden Trial in Boston (Psychosocial Intervention Group, Usual Care Group)

    Active, not recruiting
    • Malignant Glioma
    • +3 more
    • Psychosocial Intervention Group
    • Usual Care Group
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jul 12, 2022

    Malignant Glioma of Brain Trial in Chicago (Acetazolamide, Temozolomide)

    Recruiting
    • Malignant Glioma of Brain
    • Chicago, Illinois
      University of Chicago Medical Center
    Apr 1, 2022

    Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

    Active, not recruiting
    • Oligodendroglioma
    • +5 more
    • GBM6-AD and poly-ICLC before and after surgery
    • GBM6-AD and poly-ICLC after surgery only
    • San Francisco, California
      University of California
    Sep 20, 2022

    Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Boston (CARv3-TEAM-E T cells)

    Not yet recruiting
    • Glioblastoma
    • +3 more
    • CARv3-TEAM-E T cells
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Dec 13, 2022

    Malignant Glioma, Recurrent Glioblastoma Trial in Chicago (biological, other, procedure)

    Completed
    Has Results
    • Malignant Glioma
    • Recurrent Glioblastoma
    • Durvalumab
    • +3 more
    • Chicago, Illinois
      Northwestern University
    Mar 17, 2022

    Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

    Recruiting
    • Malignant Glioma of Brain
    • +8 more
    • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
    • Detroit, Michigan
      Henry Ford Health System
    Jan 9, 2023